Form 4: Insperity President and COO Granted Significant Performance-Based Stock Units

Sentiment:

Executive Compensation Grant


Insperity, Inc.'s President and COO, Arthur A. Arizpe, was granted 100,000 performance-based stock units contingent on the company's stock price reaching targets between $105 and $225 per share.

Summary

  • Arthur A. Arizpe, President and COO of Insperity, Inc. (NSP), reported his beneficial ownership and a new grant of derivative securities.
  • He directly owns 83,097 shares of Common Stock.
  • He indirectly beneficially owns 102,558 shares of Common Stock through S.C.A. Legacy, Ltd., which is controlled by Arizpe Management, LLC.
  • On July 1, 2025, Mr. Arizpe was granted 100,000 performance-based stock units (PSUs).
  • Each PSU represents a contingent right to receive one share of Insperity, Inc. common stock.
  • These PSUs are "at-risk" and will partially or fully vest at the end of a five-year period, contingent on the company's stock price achieving specified prices ranging from $105 per share to $225 per share.

Sentiment

Score: 7

Explanation: The grant of performance-based stock units to a key executive, tied to ambitious stock price targets, generally indicates management's confidence in future growth and aligns executive incentives with shareholder value, which is a positive signal. There are no negative financial results or operational issues reported.

Positives

  • The grant of 100,000 performance-based stock units aligns management incentives with long-term shareholder value creation.
  • The vesting conditions tied to significant stock price appreciation ($105-$225 per share) demonstrate confidence in future growth and ambitious targets.

Risks

  • Vesting of performance-based stock units is contingent on achieving specific stock price targets, meaning the awards may not fully vest if the targets are not met.
  • The five-year vesting period introduces long-term market and operational risks that could impact stock price performance and, consequently, the value of the PSUs.

Future Outlook

The grant of performance-based stock units with vesting tied to significant stock price appreciation ($105 to $225 per share) indicates management's long-term growth expectations and commitment to achieving higher shareholder value over a five-year period.

Management Comments

  • "Each performance-based stock unit ('PSU') represents a contingent right to receive one share of Insperity, Inc. common stock ('Common Stock') pursuant to the terms of the award agreement issued under the Insperity, Inc. Incentive Plan."
  • "The Special Performance-Based Awards are in the form of at-risk PSUs, each representing one share of Common Stock, that partially or fully vest at the end of a five-year period (except as otherwise specified in the award agreement) contingent on the Company's stock price achieving specified prices ranging from $105 per share to $225 per share."

Industry Context

Executive compensation structures, particularly those involving performance-based equity awards, are common across industries to align executive incentives with shareholder returns. The specific stock price targets reflect company-specific growth ambitions within the professional employer organization (PEO) or HR services sector.

Comparison to Industry Standards

  • Performance-based equity awards are a standard practice in executive compensation across various industries, including the PEO and HR services sector, to incentivize long-term performance.
  • The five-year vesting period for these PSUs is a relatively long-term incentive, often seen in companies aiming for sustained growth rather than short-term gains.
  • The specific stock price targets ($105-$225) are company-specific and would need to be compared against Insperity's historical performance and analyst price targets for peers like TriNet Group (TNET) or Paychex (PAYX) to fully assess their ambition relative to industry standards.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Executive Compensation PolicyGrant of performance-based stock units under the Insperity, Inc. Incentive Plan, aligning executive compensation with long-term stock performance.07/01/2025Strengthens alignment between executive incentives and shareholder value creation by tying a significant portion of compensation to ambitious stock price targets over a five-year period.

Related Party Transactions

  • Indirect beneficial ownership of 102,558 shares of Common Stock by Arthur A. Arizpe through S.C.A. Legacy, Ltd., which is controlled by Arizpe Management, LLC, where Mr. Arizpe is the Manager.

Stakeholder Impact

  • Shareholders: Potential for increased shareholder value if the company achieves the ambitious stock price targets, as executive incentives are directly tied to this performance.
  • Management/Executives: Arthur A. Arizpe's compensation is now significantly tied to the company's long-term stock performance, incentivizing strategic decisions aimed at stock price appreciation.

Next Steps

  • Monitoring Insperity, Inc.'s stock price performance relative to the $105-$225 targets over the next five years.
  • Observing future SEC filings for updates on the vesting status of these PSUs and any additional executive compensation grants.

Key Dates

DateDescription
07/01/2025Date of earliest transaction (grant of performance-based stock units) and signature date of the filing.
5-year period from 07/01/2025Vesting period for performance-based stock units, contingent on stock price targets.

Recommendation

hold

Keywords

Insperity, NSP, Form 4, SEC filing, stock units, performance-based awards, executive compensation, insider ownership, Arthur A. Arizpe, common stock

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.